Astellas Pharma

Astellas Pharma sits in the class of drugmakers people know for prescription medicines rather than for anything consumer-facing. By our assessment, its value is in that specialised pharmaceutical role: research-heavy, regulated, and built around treatments that have to satisfy doctors and health systems, not casual shoppers. The downside is the same as for much of big pharma: development is slow, evidence-driven, and expensive in ways the public rarely sees. In practice the company is far from the simple feel of a brand-name pill; it is a regulatory and scientific machine with a long path from lab to pharmacy. Compared with smaller biotech firms, it is more established and commercially broad, but also less nimble. Astellas Pharma is for people who judge a medicine maker by its portfolio and pipeline, and the country recorded for it is Japan.